Overview This page contains the latest trade data of Medicaments; containing antimalarial active principles, not packaged for retail sale. In 2023, Medicaments; containing antimalarial active principles, not packaged for retail sale were the world's 5038th most traded product, with a total trade of $26.7M. Between 2022 and 2023 the exports of Medicaments; containing antimalarial active principles, not packaged for retail sale grew by 16.4%, from $22.9M to $26.7M. Trade in Medicaments; containing antimalarial active principles, not packaged for retail sale represent 0.00012% of total world trade.
Medicaments; containing antimalarial active principles, not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....
Exports In 2023 the top exporters of Medicaments; containing antimalarial active principles, not packaged for retail sale were Lithuania ($12.7M), United States ($2.97M), India ($2.11M), Australia ($1.72M), and Canada ($1.58M).
Imports In 2023 the top importers of Medicaments; containing antimalarial active principles, not packaged for retail sale were Sweden ($12.7M), United Kingdom ($2.69M), Netherlands ($1.61M), United States ($1.58M), and Vietnam ($1.42M).
Ranking Medicaments; containing antimalarial active principles, not packaged for retail sale ranks 2883rd in the Product Complexity Index (PCI).